Loading clinical trials...
Loading clinical trials...
The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individuals living in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Miami
NCT07550010 · Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia Grade 2 (CIN2), and more
NCT07290972 · Cervical Cancer Screening, Gynecologic Cancers, and more
NCT07275333 · Cervical Cancer, Cervical Cancer Screening, and more
NCT07181278 · Cervical Cancer Screening, HIV
NCT05390567 · Cervical Cancer Screening Methods
University of Miami
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions